Phloridzin is a naturally occurring non-selective SGLT2 inhibitor, which was first associated with diabetes in the 1980s, when found to correct hyperglycemia and normalize insulin sensitivity without altering insulin levels in diabetic rats (Rossetti et al., 1987). The gene discussed is SLC5A2; the disease is diabetes mellitus.